동물용 항감염제 시장 : 동물 유형, 제품 유형, 투여 경로, 유통 채널별 - 세계 예측(2025-2030년)

The Veterinary Anti-infectives Market was valued at USD 3.84 billion in 2023, expected to reach USD 4.28 billion in 2024, and is projected to grow at a CAGR of 11.97%, to USD 8.47 billion by 2030.

The veterinary anti-infectives market encompasses a broad range of medications used to prevent, control, and treat infections in animals. This includes antibiotics, antivirals, antifungals, and antiparasitic agents. The necessity for veterinary anti-infectives is driven by the need to maintain the health and productivity of livestock, ensure food safety, and provide optimal care for companion animals. These products are applied across various end-use areas such as livestock farms, veterinary clinics, aquaculture, and companion animal shelters. Growth in this market is significantly influenced by the rising incidence of animal diseases, increasing livestock production to meet global food demand, and the expanding pet ownership trend, especially in emerging economies.

Opportunities in the market arise from advancements in drug development, particularly in creating broad-spectrum anti-infectives and those with reduced resistance potential. Regulatory changes promoting the responsible use of antibiotics also present growth avenues for alternative therapies such as probiotics and vaccines. However, the market does face limitations, including stringent regulatory requirements, high development costs, and the growing concern over antibiotic resistance. These challenges necessitate innovations in developing novel therapeutics with minimal resistance impact.

Research and innovation can focus on enhancing drug efficacy, developing rapid diagnostic tools to reduce misuse of antibiotics, and exploring natural or synthetic alternatives to traditional antimicrobials. The best areas for innovation could be in the formulation of combination drugs or new delivery mechanisms that improve treatment outcomes. Understanding the market's nature, which is shifting towards sustainability and minimal environmental impact, is vital for guiding business strategies.

The complex landscape of veterinary anti-infectives requires a multifaceted approach to research and development, with emphasis on collaboration between industry players, academia, and regulatory bodies to overcome challenges and harness emerging opportunities effectively. By prioritizing precision medicine and integrated farming practices, businesses can better align with market demands and regulatory criteria, paving the way for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Anti-infectives Market

The Veterinary Anti-infectives Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing awareness regarding animal healthcare
  • Rising incidence of zoonotic diseases
  • Increasing adoption of companion animals with rising concerns to pet wellbeing
• Market Restraints
  • High cost of veterinary services
• Market Opportunities
  • Favorable initiatives by various government agencies and animal associations
  • Growing R&D activities in the animal healthcare
• Market Challenges
  • Threat associated with counterfeit medicines

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Anti-infectives Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Anti-infectives Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Anti-infectives Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Anti-infectives Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Anti-infectives Market

A detailed market share analysis in the Veterinary Anti-infectives Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Anti-infectives Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Anti-infectives Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Anti-infectives Market

A strategic analysis of the Veterinary Anti-infectives Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Anti-infectives Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Huvepharma, Inc., Merck & Co., Inc., Neogen Corporation, Nutreco N.V., Perrigo Company PLC, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Anti-infectives Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Animal Type, market is studied across Companion Animal and Livestock. The Companion Animal is further studied across Cat and Dog. The Livestock is further studied across Cattle, Fish, Poultry, Sheep & Goats, and Swine.
• Based on Product Type, market is studied across Antibacterial, Antifungals, and Antivirals. The Antibacterial is further studied across Cephalosporins, Macrolides, Penicillin, and Tetracyclines.
• Based on Route of Administration, market is studied across Injectables and Oral.
• Based on Distribution Channel, market is studied across E-Commerce, Retail Pharmacies, and Veterinary Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing awareness regarding animal healthcare
    • 5.1.1.2. Rising incidence of zoonotic diseases
    • 5.1.1.3. Increasing adoption of companion animals with rising concerns to pet wellbeing
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of veterinary services
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable initiatives by various government agencies and animal associations
    • 5.1.3.2. Growing R&D activities in the animal healthcare
  • 5.1.4. Challenges
    • 5.1.4.1. Threat associated with counterfeit medicines
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Anti-infectives Market, by Animal Type

• 6.1. Introduction
• 6.2. Companion Animal
  • 6.2.1. Cat
  • 6.2.2. Dog
• 6.3. Livestock
  • 6.3.1. Cattle
  • 6.3.2. Fish
  • 6.3.3. Poultry
  • 6.3.4. Sheep & Goats
  • 6.3.5. Swine

7. Veterinary Anti-infectives Market, by Product Type

• 7.1. Introduction
• 7.2. Antibacterial
  • 7.2.1. Cephalosporins
  • 7.2.2. Macrolides
  • 7.2.3. Penicillin
  • 7.2.4. Tetracyclines
• 7.3. Antifungals
• 7.4. Antivirals

8. Veterinary Anti-infectives Market, by Route of Administration

• 8.1. Introduction
• 8.2. Injectables
• 8.3. Oral

9. Veterinary Anti-infectives Market, by Distribution Channel

• 9.1. Introduction
• 9.2. E-Commerce
• 9.3. Retail Pharmacies
• 9.4. Veterinary Clinics

10. Americas Veterinary Anti-infectives Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Veterinary Anti-infectives Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Anti-infectives Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Biogenesis Bago SA
• 2. Boehringer Ingelheim International GmbH
• 3. Ceva Sante Animale
• 4. Dechra Pharmaceuticals PLC
• 5. Elanco Animal Health Incorporated
• 6. Evonik Industries AG
• 7. Hester Biosciences Limited
• 8. Huvepharma, Inc.
• 9. Merck & Co., Inc.
• 10. Neogen Corporation
• 11. Nutreco N.V.
• 12. Perrigo Company PLC
• 13. Vetoquinol S.A.
• 14. Virbac S.A.
• 15. Zoetis Inc.